|
TP1053L |
Protein Kinase C 19-31 acetate
|
Protein Kinase C 19-31 acetate(121545-65-1 free base),PKC (19-31) acetate |
PKC
|
|
Protein Kinase C 19-31 acetate, a peptide inhibitor of protein kinase C (PKC), derived from the pseudo-substrate regulatory domain of PKCa (residues 19-31) with a serine at position 25 replacing the wild-type alanine, is... |
|
TP1053 |
Protein Kinase C (19-31)
|
Protein Kinase C 19-31,PKC (19-31) |
|
|
Protein Kinase C (19-31), a peptide inhibitor of protein kinase C (PKC), derived from the pseudo-substrate regulatory domain of PKCa (residues 19-31) with a serine at position 25 replacing the wild-type alanine, is used ... |
|
TP1052 |
Protein Kinase C (19-31) (TFA)(121545-65-1,free)
|
PKC (19-31) (TFA),Protein Kinase C (19-31) (TFA) |
|
|
Protein Kinase C (19-31) TFA, a peptide inhibitor of protein kinase C (PKC), derived from the pseudo-substrate regulatory domain of PKCa (residues 19-31) with a serine at position 25 replacing the wild-type alanine, is u... |
|
T76008 |
Protein Kinase C (19-31) (TFA)
|
|
|
|
Protein Kinase C (19-31) TFA is a peptide inhibitor derived from the pseudo-substrate regulatory domain of PKCa (residues 19-31), featuring a serine substitution for alanine at position 25. It serves as a substrate pepti... |
|
TP1955 |
PKC β pseudosubstrate
|
|
|
|
Selective cell-permeable peptide inhibitor of protein kinase C (IC50 ~ 0.5 μM). Consists of amino acids 19 - 31 of PKC pseudosubstrate domain linked by a disulphide bridge to a cell permeabilisation Antennapedia domain v... |
